A detailed history of Whitebox Advisors LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Whitebox Advisors LLC holds 1,566,501 shares of VRNA stock, worth $167 Million. This represents 8.34% of its overall portfolio holdings.

Number of Shares
1,566,501
Holding current value
$167 Million
% of portfolio
8.34%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$90.08 - $106.69 $141 Million - $167 Million
1,566,501 New
1,566,501 $167 Million

Others Institutions Holding VRNA

About Verona Pharma plc


  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $6.52B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Whitebox Advisors LLC Portfolio

Follow Whitebox Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whitebox Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Whitebox Advisors LLC with notifications on news.